Cognition Therapeutics Inc. is a drug discovery and development company located in Pittsburgh, Pennsylvania. Cognition Therapeutics is focused on the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other neuro- degenerative diseases of the human brain. ( acquired by IPO )